Table 6.
Mean (S.D.) SP-WB | Sample Size | p-value comparing present study to all others | Population Description | |
---|---|---|---|---|
Harris et al | 37.06 (9.5) | 52 | cGVHD after HSCT | |
Andrykowski et al | 35.9 (8.6) | 662 | 0.25 | HSCT survivors |
Robb et al | 33.46 (6.11) | 127 | 0.0059 | Breast cancer survivors |
Tate et al | 38.5 (7.8) | 208 | 0.76 | Breast Cancer (terminal patients excluded) |
Cotton et al | 28.34 (9.24) | 142 | <0.0001 | Breast Cancer-diagnosed within the last 18 months |
Peterman et al | 38.5 (8.1) | 1617 | 0.76 | Cancer - All types |
Daugherty et al | 40.7 (7.2) | 162 | 0.09 | Advanced Cancer and participating in Phase I Trials |